Radiometer, a provider of acute care testing solutions, has added the cardiac marker Troponin T (TnT) to its AQT90 Flex immunoassay analyzer for use at the point of care.
The AQT90 Flex helps emergency departments to ensure a fast and accurate process for ruling in/out acute myocardial infarction (AMI) patients avoiding consuming procedures.
According to European Society of Cardiology and American College of Cardiology guidelines, TnT is used for AMI detection as its turnaround time is less than 60 minutes.
Radiometer said that on the AQT90 Flex analyzer, TnT results are available at the point of care in just 12 minutes enabling caregivers to meet recommended guidelines and shows a performance comparable to lab assays at the point of care.
Radiometer president Peter Kurstein said that the new marker enables healthcare professionals to improve processes in emergency rooms and labs, ultimately helping hospitals improve patient care and reduce costs.
“Clinicians have the results when and where they need them, without having to wait for the lab or deal with the hassles of manual testing,” Kurstein said.
“This not only has the potential to reduce overall costs, but also enables hospitals as a whole to better focus their resources on the critically ill and on improving patient care.”